JulieAnn Rader

JulieAnn Rader

UNVERIFIED PROFILE

Are you JulieAnn Rader?   Register this Author

Register author
JulieAnn Rader

JulieAnn Rader

Publications by authors named "JulieAnn Rader"

Are you JulieAnn Rader?   Register this Author

8Publications

385Reads

5Profile Views

Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.

Clin Cancer Res 2017 Apr 11;23(7):1785-1796. Epub 2016 Oct 11.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1131DOI Listing
April 2017

A novel approach for next-generation sequencing of circulating tumor cells.

Mol Genet Genomic Med 2016 Jul 28;4(4):395-406. Epub 2016 Feb 28.

Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania; Abramson Cancer CenterUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947859PMC
July 2016

Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.

Front Oncol 2014 31;4:201. Epub 2014 Jul 31.

Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia , Philadelphia, PA , USA ; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/articles/10.3389/fonc.2014.00201
Web Search
http://journal.frontiersin.org/article/10.3389/fonc.2014.002
Publisher Site
http://dx.doi.org/10.3389/fonc.2014.00201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116800PMC
August 2014

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Clin Cancer Res 2013 Nov 17;19(22):6173-82. Epub 2013 Sep 17.

Authors' Affiliations: Division of Oncology and Center for Childhood Cancer Research; Division of Pathology, Children's Hospital of Philadelphia; Department of Pediatrics; Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844928PMC
November 2013

CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity.

Cell Cycle 2013 Jul;12(14):2210-8

Pediatric Oncology Branch; National Cancer Institute; Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.25265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755071PMC
July 2013

Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.

Cancer Res 2013 Jan 7;73(2):776-84. Epub 2012 Nov 7.

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548976PMC
January 2013